Gossamer Bio Inc GOSS

US Biotechnology
$0.17 β–Ό -4.94% ($-0.01)
🎢 High Beta 📅 Earnings This Week
Open $0.18
Prev Close $0.18
Day Range $0.17 – $0.18
52W Range $0.11 – $3.87
Market Cap $82.86M
Beta 2.02
EPS (TTM) $-0.78

πŸ“‹ Company Profile

IndustryBiotechnology
CountryUS
ExchangeNASDAQ NMS - GLOBAL MARKET
CurrencyUSD
IPO Date2019-02-08
Shares Out.488,850,000
Websitegossamerbio.com/ β†—
Phone13026365400
Employees162
Revenue$17.0M
Gross Profit$17.0M
Net Income-$46.7M
Free Cash Flow-$170.3M
Total Assets$128.9M
Total Liabilities$290.4M
Equity-$161.5M
About Gossamer Bio Inc

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension).

Gossamer Bio Inc is a publicly traded company under the ticker symbol GOSS on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.

πŸ“Š Analyst Ratings

14 analysts (2026-07-01)

Strong Buy 2
Buy 6
Hold 5
Sell 1

πŸ“° Latest News for GOSS

πŸ‘₯ Related Stocks